Detailed Information on Publication Record
2021
Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant
ŠTORK, Martin, Renata BEZDĚKOVÁ, Romana KRÁLOVÁ, Viera SANDECKÁ, Zdeněk ADAM et. al.Basic information
Original name
Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant
Authors
ŠTORK, Martin (203 Czech Republic), Renata BEZDĚKOVÁ (203 Czech Republic), Romana KRÁLOVÁ (203 Czech Republic), Viera SANDECKÁ (703 Slovakia, guarantor), Zdeněk ADAM (203 Czech Republic), Marta KREJČÍ (203 Czech Republic), Ivanna BOICHUK (804 Ukraine), Zdeňka KNECHTOVÁ (203 Czech Republic), Lucie BROŽOVÁ (203 Czech Republic), Sabina ŠEVČÍKOVÁ (203 Czech Republic, belonging to the institution), Lucie ŘÍHOVÁ (203 Czech Republic) and Luděk POUR (203 Czech Republic)
Edition
Neoplasma, Bratislava, Slovenská akademie vied, 2021, 0028-2685
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Slovakia
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.409
RIV identification code
RIV/00216224:14110/21:00120121
Organization unit
Faculty of Medicine
UT WoS
000662144000007
Keywords in English
multiple myeloma; minimal residual disease; lymphocyte; flow cytometry
Tags
International impact, Reviewed
Změněno: 23/8/2021 11:02, Mgr. Tereza Miškechová
Abstract
V originále
Despite the high efficacy of current induction regimens, most multiple myeloma (MM) patients relapse over time. The link between changes in the immune system and the prognosis of the disease is still not entirely clear. Therefore, we analyzed whether the pattern of bone marrow (BM) lymphocytes during routine BM examination after autologous stem cell transplant (ASCT) is related to disease prognosis or MRD negative complete remission. From 2009 to 2018, 98 MM patients underwent routine BM testing after the first ASCT. Using multi-parametric flow cytometry, twelve BM lymphocyte subtypes were analyzed. In 60% of patients who achieved a complete response (CR), MRD by flow cytometric analysis (sensitivity threshold 10-6) was evaluated. We found an association of relative proportion of BM lymphocyte subtypes with treatment response, progression-free survival (PFS), overall survival (OS), and minimal residual disease (MRD) negativity. Higher relative proportion of memory B cells was associated with inferior median PFS [HR 1.089 (95% CI: 1.023-1.160), p=0.0081 and median OS [HR 1.170 (95% CI: 1.074-1.274), p<0.001]. In non-responding patients (minimal response and worse), higher proportion of memory B cells was found when compared to patients achieving CR [3.8% (range 0.5-35.0) vs. 1.0% (range 0.1-12.5); p=0.0011. No significant association of BM lymphocyte subtypes proportion with MRD negative CR was found. Our results show that changes in BM lymphocyte subsets including memory B cells may have prognostic value in MM patients after ASCT.
Links
NV17-29343A, research and development project |
|